EM-2 inhibited autophagy and promoted G2/M phase arrest and apoptosis by activating the JNK pathway in hepatocellular carcinoma cells

• 作者: Jie Yang Zhen-dong Li Chang-yan Hou Zi-yu Li Qiang Li Shen-yu Miao Qing Zhang Xiao-ying Zhang Xiao-feng Zhu Jian-wei Jiang
• 来源期刊: 中国药理学报（英文版）
• 年，卷（期）: 2021,（7）
• 所属期刊栏目: Anti-tumor Pharmacology
• 页码范围: 1139-1149
• 页数: 11页
• 语种: 英文

摘要

This study aimed to investigate the inhibitory effect of EM-2,a natural active monomer purified from Elephantopusmollis H.B.K.,on the proliferation of human hepatocellular carcinoma cells and the molecular mechanism involved.The results from the MTT assay revealed that EM-2 significantly inhibited the proliferation of human hepatocellular carcinoma(HCC)cells in a dose-dependent manner but exhibited less cytotoxicity to the normal liver epithelial cell line LO2.EdU staining and colony formation assays further confirmed the inhibitory effect of EM-2 on the proliferation of Huh-7 hepatocellular carcinoma cells.According to the RNA sequencing and KEGG enrichment analysis results,EM-2 markedly activated the MAPK pathway in Huh-7 cells,and the results of Western blotting further indicated that EM-2 could activate the ERK and JNK pathways.Meanwhile,EM-2 induced apoptosis in a dose-dependent manner and G2/M phase arrest in Huh-7 cells,which could be partially reversed when treated with SP600125,a JNK inhibitor.Further study indicated that EM-2 induced endoplasmic reticulum stress and blocked autophagic flux in Huh-7 cells by inhibiting autophagy-induced lysosome maturation.Inhibition of autophagy by bafilomycin A1 could reduce cell viability and increase the sensitivity of Huh-7 cells to EM-2.In conclusion,our findings revealed that EM-2 not only promoted G2/M phase arrest and activated ER stress but also induced apoptosis by activating the JNK pathway and blocked autophagic flux by inhibiting autolysosome maturation in Huh-7 hepatocellular carcinoma cells.Therefore,EM-2 is a potential therapeutic drug with promising antitumor effects against hepatocellular carcinoma and fewer side effects.